Apellis Pharmaceuticals
APLS
$40.79
Share price
1.14%
Change (1 day)
-54.31%
Change (1 year)
Categories
Apellis Pharmaceuticals (APLS) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $0.56 B
According to Apellis Pharmaceuticals's latest financial reports the company's total liabilities are $0.56 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Apellis Pharmaceuticals - Total liabilities on balance sheet (from 2014 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.59 B | 0.65% |
| 2022-12-31 | $0.59 B | -13.58% |
| 2021-12-31 | $0.68 B | -9.64% |
| 2020-12-31 | $0.75 B | 112.95% |
| 2019-12-31 | $0.35 B | 734.14% |
| 2018-12-31 | $42.56 M | 28.24% |
| 2017-12-31 | $33.18 M | 812.04% |
| 2016-12-31 | $3.63 M | 13.71% |
| 2015-12-31 | $3.2 M | 195.89% |
| 2014-12-31 | $1.08 M | 59.76% |
| 2013-12-31 | $0.67 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $22.14 M | -96.08% | 🇺🇸 USA |